Menopause Hormone Therapy: Options, Benefits, and Risks
Hormone therapy can reduce hot flashes, night sweats, and some vaginal symptoms during the menopausal transition. The right treatment depends on which symptoms affect you, whether you have a uterus, your health history, and your preferences. Different products do different jobs, so one person's prescription cannot serve as a template for everyone else.
Some treatments deliver hormones throughout the body. Others act mainly in vaginal tissue. Nonhormonal medicines offer another approach for selected symptoms, but they do not become hormone therapy simply because clinicians use them during menopause.
Understand the stage of the transition
Perimenopause describes the years when ovarian hormone patterns change and menstrual cycles become less predictable. It often begins in the 40s, although the timing varies. Estrogen and progesterone can fluctuate rather than falling steadily, which helps explain why symptoms and bleeding differ from month to month.
Menopause marks twelve consecutive months without a period when another cause does not explain the absence. Postmenopause describes the years after that point. Symptoms do not necessarily end with the final period; hot flashes, sleep disruption, and vaginal discomfort can continue.
Pregnancy remains possible during perimenopause because ovulation can still occur. Menopause hormone therapy does not provide contraception. If you need pregnancy prevention, discuss it explicitly rather than assuming that irregular periods or an estrogen prescription have removed the possibility.
Early loss of ovarian function, removal of the ovaries, and some medical treatments can produce a different situation from the usual transition. Tell the clinician how and when your symptoms began so they can consider that history when assessing benefits and risks.

Identify the symptoms you want to treat
Hot flashes can bring sudden warmth, sweating, and a fast heartbeat. At night they may disrupt sleep or leave bedding damp. Some people have occasional mild episodes; others struggle to work, sleep, or remain comfortable through the day.
Sleep problems can occur with or without night sweats. Mood changes, irritability, anxiety, low mood, and difficulty concentrating can overlap with sleep loss and other stresses. Do not assume that every memory concern, headache, or mood symptom comes from estrogen alone.
Periods may become longer, shorter, heavier, lighter, or less frequent. Vaginal dryness, burning, painful sex, urinary urgency, leakage, or recurrent urinary infections may also appear. These symptoms deserve their own assessment because other conditions can resemble menopause-related changes.
Keep a short record of timing, intensity, bleeding, and interference with daily life. A list of priorities helps the clinician choose treatment: stopping night sweats requires a different discussion from treating vaginal discomfort alone.
What hormone therapy can reasonably achieve
Systemic hormone therapy can relieve vasomotor symptoms such as hot flashes and night sweats. Better sleep may follow when night sweats improve. Estrogen also helps prevent bone loss while treatment continues, although the decision to prescribe should consider the person's full risk profile.
Therapy does not stop reproductive aging, reverse menopause, or guarantee a change in weight, memory, libido, or mood. Some symptoms need a separate diagnosis or treatment. A prescription that reduces hot flashes may not resolve sleep apnea, depression, pain, or relationship concerns.
Menopause itself does not require treatment for everyone. Symptoms and circumstances guide the choice. You can ask for help when symptoms disrupt life without needing to prove that the transition is an illness.
Separate systemic and local estrogen
Systemic treatment delivers estrogen throughout the body through an oral tablet or an appropriate skin product, such as a patch or gel. Clinicians may use it for hot flashes and other symptoms when the expected benefits outweigh the risks.
Low-dose vaginal estrogen targets vaginal and nearby urinary tissue. It can help dryness, discomfort, and painful sex, but it does not provide the same treatment for hot flashes. Vaginal tablets, creams, inserts, and rings have product-specific instructions.
Not every vaginal estrogen product has the same dose or systemic exposure. Ask which type you have and what it should treat. A cream applied to body skin also differs from a cream intended for vaginal use; the word cream does not identify the treatment route or its risks.
If vaginal symptoms provide the only reason for treatment, discuss whether a local approach fits. Nonhormonal moisturizers and lubricants may also help comfort, although persistent pain or bleeding needs assessment rather than repeated self-treatment.
Why a uterus changes the prescription
Systemic estrogen without adequate progestogen protection can stimulate the uterine lining and increase the risk of endometrial cancer in someone with a uterus. Clinicians usually add a suitable progestogen when prescribing systemic estrogen in this situation.
Progesterone is a hormone. Progestins are synthetic medicines with related actions; the broader term progestogen includes both. They are not interchangeable words for exactly the same ingredient, and products can differ in their effects and instructions.
A clinician may prescribe the progestogen continuously or on a cyclic schedule. Follow the complete regimen rather than taking estrogen while skipping the part intended to protect the lining. If you have had a hysterectomy, the discussion can differ, although your medical history still matters.
Low-dose local vaginal estrogen generally does not require the same routine progestogen addition as systemic estrogen. The actual product and circumstances matter. Report new or unexplained bleeding even if you use a local treatment.
Review health history before choosing a route
Systemic hormone therapy may not suit someone with a history of certain hormone-sensitive cancers, unexplained vaginal bleeding, blood clots, stroke, heart attack, significant liver disease, or other conditions that change risk. The clinician needs the details rather than only a general statement that you have a family history of illness.
Systemic hormone therapy can increase the risk of blood clots and stroke, with the balance depending on the route, dose, age, and medical history. Combined estrogen-progestogen treatment can increase breast cancer risk, particularly with longer use. Estrogen without appropriate uterine protection carries a separate endometrial cancer risk. Ask how each risk applies to the proposed regimen rather than treating all hormone products as equivalent.
Age and the time since menopause influence the balance of benefits and risks. The discussion differs between a healthy person near menopause with troublesome symptoms and someone beginning systemic treatment much later. No single warning applies in exactly the same way to every age, route, dose, or formulation.
Tell the clinician about migraines, blood pressure, smoking, diabetes, previous breast or uterine problems, pregnancy possibility, and all medicines. A personal history of a clot matters differently from a vague concern about a distant relative.
Do not start hormone therapy to prevent heart disease or dementia. Reports of risk from particular studies need context, and they do not justify either a promise of protection or a blanket claim that every menopause prescription causes those conditions.
What the initial assessment may involve
Clinicians often assess perimenopause from age, menstrual history, symptoms, and medical history. Hormone levels fluctuate, so one blood result may not establish a clear stage or identify a perfect level that treatment must reach.
Testing can help when symptoms occur unusually early, another condition seems possible, or a particular medicine requires monitoring. Depending on the history, the clinician may consider pregnancy testing, thyroid evaluation, blood pressure, cardiovascular risk, or bone health.
Bleeding between periods, after sex, or after menopause needs attention. Very heavy or prolonged bleeding also deserves assessment. Do not use a hormone prescription to cover unexplained bleeding without discussing the cause.
Bring the names and doses of contraceptives and other hormone products. They can change bleeding patterns and influence which treatments fit together. The appointment should establish the goal and a follow-up plan, not merely select a product from a list.
Skin patches and other transdermal products
Estradiol patches deliver estrogen through the skin. Different products require replacement at different intervals, often once or twice weekly. Apply the patch to the site specified in its instructions rather than assuming every brand uses the same location.
Skin irritation can occur at the application site. Breast tenderness, headache, bloating, nausea, or bleeding changes can also occur with systemic treatment. Tell the prescriber if symptoms persist, become troublesome, or differ from the expected adjustment period.
Transdermal estrogen avoids the same first pass through the liver as oral estrogen, which can matter in a discussion about clot risk and other factors. It does not remove all risks or the need for progestogen protection when appropriate.
Some systemic gels, sprays, or other skin formulations require precautions against transfer to another person's skin. Follow the product's instructions about handwashing, drying, covering the area, bathing, and close contact. A compounded cream may have different evidence and consistency from an approved product; ask exactly what the clinician proposes.
Oral estrogen
Oral estradiol provides a systemic option for suitable patients. It may suit someone who cannot tolerate a skin product or prefers a tablet, but the route affects how the body processes the medicine. Follow the actual prescription for timing and use with food.
Possible adverse effects include breast tenderness, nausea, bloating, headache, and changes in bleeding. Oral estrogen can carry a different blood clot risk profile from transdermal treatment. The clinician should consider that difference alongside the person's history rather than treating every route as identical.
Do not switch from a patch to a tablet, use both to make up for a missed application, or change the dose according to a difficult night of symptoms without instructions. Ask how to handle missed doses and what to do if a product becomes unavailable.
Local treatment for vaginal and urinary symptoms
Low-dose vaginal estrogen may help tissue changes associated with dryness, burning, and pain during sex. Some products begin with a more frequent introductory schedule and then move to maintenance use. The product instructions determine the dose and frequency.
Local treatment does not generally relieve night sweats or hot flashes elsewhere in the body. If those symptoms also trouble you, discuss them separately. You may need a different approach rather than repeatedly increasing a local medicine.
Report vaginal bleeding, persistent pain, unusual discharge, or symptoms that do not improve. A urinary infection, skin disorder, pelvic floor problem, or another condition may need treatment alongside or instead of estrogen.
A history of breast cancer or another hormone-sensitive condition needs an individual conversation with the appropriate care team. Do not assume either that every local product is forbidden or that low exposure makes the history irrelevant.
Progesterone and progestin options
When a clinician adds a progestogen to systemic estrogen, a main purpose is protecting the uterine lining. The appropriate medicine and schedule depend on the estrogen regimen and your circumstances. Some products combine ingredients; others require separate prescriptions.
Oral micronized progesterone can cause sleepiness or dizziness, and the instructions may specify taking it at bedtime. Other possible effects include breast tenderness, bloating, headache, and mood or bleeding changes. Different progestins can have different profiles.
Tell the clinician if you struggle to take this part of the regimen. Do not simply leave it out while continuing systemic estrogen. Ask about alternatives, expected bleeding patterns, and which symptoms should lead to a review.
Contraceptive pills during perimenopause
For some people who still need contraception, a combined hormonal contraceptive can help with bleeding control and some transition symptoms. These products contain an estrogen and a progestin, but not every pill contains the same estrogen or dose.
Combined contraceptives and menopause hormone therapy are different regimens with different purposes and risk assessments. Smoking, migraine with aura, blood clot history, blood pressure, and age can influence whether a combined contraceptive suits you.
Possible effects include nausea, breast tenderness, headaches, and spotting or other bleeding changes. A clinician should help plan when and how to move from contraception to another approach, rather than layering products without a review.
Nonhormonal treatment for hot flashes
Fezolinetant, sold as Veozah, is a nonhormonal treatment for moderate to severe vasomotor symptoms. It acts on a brain pathway involved in temperature regulation. It does not provide estrogen, protect the uterine lining, or serve as contraception.
This medicine can cause serious liver injury. Current prescribing instructions require liver tests before treatment, monthly during the first three months, and again at months six and nine. Other liver or kidney conditions and certain medicines can rule it out, so the prescriber needs a complete review.
Stop the medicine and contact the clinician promptly if you develop symptoms such as unusual fatigue, loss of appetite, persistent nausea or vomiting, abdominal pain, itching, dark urine, pale stools, or yellow skin or eyes. Do not wait for the next planned blood test when symptoms suggest liver injury.
Other nonhormonal prescriptions may help selected patients too. Ask which symptom the medicine targets, what evidence supports it, and how side effects or interactions compare with your alternatives.
Plan follow-up around benefit and tolerability
Agree on what improvement would make treatment worthwhile: fewer awakenings, less disruptive hot flashes, more comfortable sex, or another specific goal. Ask how long to try the regimen before reviewing it and which effects should prompt earlier contact.
Some side effects settle, but persistent bleeding, severe headaches, or other new symptoms need assessment. Chest pain, sudden breathlessness, signs of a stroke, or a painful swollen leg call for urgent care. Do not treat them as an ordinary adjustment to hormones.
Review the dose, route, need for ongoing treatment, and any changes in health over time. There is no universal date when everyone must stop, and continuing indefinitely without reassessment also misses the point. The decision should reflect current benefits, risks, and preferences.
If you decide to stop, ask how the clinician recommends doing so and what to expect if symptoms return. Vaginal symptoms may need a different long-term approach from hot flashes. Keep contraception in the discussion until the clinician confirms that you no longer need it.
Sources
- American College of Obstetricians and Gynecologists. Hormone Therapy for Menopause. https://www.acog.org/womens-health/faqs/hormone-therapy-for-menopause
- American College of Obstetricians and Gynecologists. The Menopause Years. https://www.acog.org/womens-health/faqs/the-menopause-years
- Food and Drug Administration. Serious liver injury warning for fezolinetant. https://www.fda.gov/drugs/drug-safety-communications/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due
Related reading
- When Does Perimenopause Start?
- Understanding Cold Sores: Symptoms, Spread, and Everyday Care
- Health Guide
Medical Disclaimer: This content is provided for informational and educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. Always consult a qualified physician or licensed healthcare provider with any questions regarding a medical condition or prescription medication. Read our Editorial & Medical Review Policy.
